Last news
Keymed Biosciences | The Latest Results from the Phase Ia Clinical Study of CMG901 was presented at the 2023 ASCO GI CANCERS SYMPOSIUM

Keymed Biosciences | The Latest Results from the Phase Ia Clinical Study of CMG901 was presented at the 2023 ASCO GI CANCERS SYMPOSIUM

...

Mental health focus makes Boehringer Ingelheim stand out as Top Employer 2023 in Asia Pacific for Third Consecutive Year

Mental health focus makes Boehringer Ingelheim stand out as Top Employer 2023 in Asia Pacific for Third Consecutive Year

...

Telix Reports Fourth Quarter 2022 Financial Results

Telix Reports Fourth Quarter 2022 Financial Results

...

Tech downturn slashes billions from value of world's top brands

Tech downturn slashes billions from value of world's top brands

...

IASO Bio Raises Nearly $75 Million in Series C1 Funding

IASO Bio Raises Nearly $75 Million in Series C1 Funding

...

Transcenta to Present "Trial in Progress" at ASCO-GI 2023 for TST001 (Osemitamab) Combination with Nivolumab, with or without Chemotherapy in Advanced G/GEJ Cancer

Transcenta to Present "Trial in Progress" at ASCO-GI 2023 for TST001 (Osemitamab) Combination with Nivolumab, with or without Chemotherapy in Advanced G/GEJ Cancer

...

Everest Medicines Announces Top-line Data from Phase I Study of EVER206 on Healthy Subjects in China

Everest Medicines Announces Top-line Data from Phase I Study of EVER206 on Healthy Subjects in China

...

Asieris Appoints Dr. Linda Wu as Chief Development Officer

Asieris Appoints Dr. Linda Wu as Chief Development Officer

...

menu
menu